Cancer Research SABCS  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delikatny, E. J.
Right arrow Articles by Rideout, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delikatny, E. J.
Right arrow Articles by Rideout, D. C.
[Cancer Research 62, 1394-1400, March 1, 2002]
© 2002 American Association for Cancer Research


Experimental Therapeutics

Nuclear Magnetic Resonance-visible Lipids Induced by Cationic Lipophilic Chemotherapeutic Agents Are Accompanied by Increased Lipid Droplet Formation and Damaged Mitochondria1

Edward J. Delikatny2, Wendy A. Cooper, Susan Brammah, Nalayini Sathasivam and Darryl C. Rideout

Department of Cancer Medicine, The University of Sydney, New South Wales 2006, Australia [E. J. D., W. A. C., N. S.]; Central Sydney Area Health Service Electron Microscopy Unit, Concord Hospital, Concord, New South Wales 2139, Australia [S. B.]; and Darryl Rideout Structural Bioinformatics, Inc., San Diego, California [D. C. R.]

Proton nuclear magnetic resonance (NMR) spectroscopy, histological lipid staining, and electron microscopy were used to assess the biochemical and structural changes induced by treating the cultured human breast cell line HBL-100 with the cationic lipophilic phosphonium salts p-(triphenylphosphoniummethyl) benzaldehyde chloride (drug A) and [4-(hydrazinocarboxy)-1-butyl] tris-(4-dimethylaminophenyl) phosphonium chloride (drug B). The major biochemical change detected by 1H NMR in drug-treated cells was a significant time- and concentration-dependent increase in lipid acyl chain resonances arising from mobile lipids. The amount of NMR-visible lipid strongly correlated with morphometric measurements of oil red O-staining lipid detected in the cytoplasm by light microscopy. Ultrastructural investigations revealed substantial damage to mitochondria and the progressive development of lipid droplets accompanied by end-stage autophagic vacuoles, in the form of densely staining myelinoid bodies, after treatment of HBL-100 cells with drug B at the IC50. No apparent increase in acid phosphatase activity was observed using electron microscopy, indicating that the accumulation of phospholipids in myelinoid bodies may result from substrate inundation of the lysosome, rather than increased lysosomal activity. These results indicate a potential role for lysosomal lipid catabolism in the formation of NMR-visible lipids in models of cytotoxic insult.




This article has been cited by other articles:


Home page
J Electron Microsc (Tokyo)Home page
G. J. Arismendi-Morillo and A. V. Castellano-Ramirez
Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies
J. Electron Microsc. (Tokyo), January 1, 2008; 57(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Glunde, V. Raman, N. Mori, and Z. M. Bhujwalla
RNA Interference-Mediated Choline Kinase Suppression in Breast Cancer Cells Induces Differentiation and Reduces Proliferation
Cancer Res., December 1, 2005; 65(23): 11034 - 11043.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Lindskog, C. Spenger, J. Jarvet, A. Graslund, and P. Kogner
Predicting Resistance or Response to Chemotherapy by Proton Magnetic Resonance Spectroscopy in Neuroblastoma
J Natl Cancer Inst, October 6, 2004; 96(19): 1457 - 1466.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. L. Griffin, K. K. Lehtimaki, P. K. Valonen, O. H. J. Grohn, M. I. Kettunen, S. Yla-Herttuala, A. Pitkanen, J. K. Nicholson, and R. A. Kauppinen
Assignment of 1H Nuclear Magnetic Resonance Visible Polyunsaturated Fatty Acids in BT4C Gliomas Undergoing Ganciclovir-Thymidine Kinase Gene Therapy-induced Programmed Cell Death
Cancer Res., June 15, 2003; 63(12): 3195 - 3201.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.